Erste Asset Management’s Denali Therapeutics DNLI Stock Holding History

Erste Asset Management’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$696K	Hold	26,900	–	–	0.01%	486
2026 Q1	$486K	Hold	26,900	–	–	﹤0.01%	513
2025 Q4	$446K	Hold	26,900	–	–	﹤0.01%	514
2025 Q3	$391K	Hold	26,900	–	–	﹤0.01%	507
2025 Q2	$379K	Hold	26,900	–	–	﹤0.01%	673
2025 Q1	$398K	Hold	26,900	–	–	0.01%	444
2024 Q4	$554K	Hold	26,900	–	–	0.01%	432
2024 Q3	$792K	Hold	26,900	–	–	0.01%	400
2024 Q2	$618K	Hold	26,900	–	–	0.01%	407
2024 Q1	$559K	Hold	26,900	–	–	0.01%	411
2023 Q4	$590K	Sell	26,900 -307,769	-92%	-$6.1M	0.01%	414
2023 Q3	$684K	Buy	334,669 +307,769	+1,144%	+$7.81M	0.01%	378
2023 Q2	$790K	Hold	26,900	–	–	0.01%	383
2023 Q1	$589K	Hold	26,900	–	–	0.01%	413
2022 Q4	$757K	Hold	26,900	–	–	0.02%	387
2022 Q3	$788K	Hold	26,900	–	–	0.02%	375
2022 Q2	$780K	Hold	26,900	–	–	0.02%	385
2022 Q1	$872K	Sell	26,900 -3,700	-12%	-$127K	0.02%	372
2021 Q4	$1.35M	Hold	30,600	–	–	0.02%	328
2021 Q3	$1.51M	Hold	30,600	–	–	0.03%	301
2021 Q2	$2.35M	Hold	30,600	–	–	0.05%	271
2021 Q1	$1.66M	Hold	30,600	–	–	0.04%	295
2020 Q4	$2.57M	Sell	30,600 -111,600	-78%	-$6.75M	0.07%	240
2020 Q3	$5.11M	Hold	142,200	–	–	0.17%	142
2020 Q2	$3.42M	Hold	142,200	–	–	0.14%	169
2020 Q1	$2.58M	Hold	142,200	–	–	0.15%	163
2019 Q4	$2.5M	Hold	142,200	–	–	0.11%	183
2019 Q3	$2.2M	Hold	142,200	–	–	0.12%	172
2019 Q2	$2.94M	Buy	142,200 +100,000	+237%	+$2.24M	0.16%	139
2019 Q1	$944K	Buy	42,200 +29,000	+220%	+$607K	0.05%	251
2018 Q4	$257K	Buy	+13,200	New	+$239K	0.02%	350

Other funds holding DNLI

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

YMRC

Yorktown Management & Research Company Forest, Virginia $163M AUM 68.53% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

SOAM

SBI Okasan Asset Management Tokyo, Japan $3.04B AUM

Erste Asset Management's DNLI Position: Q2 2026 in Review

Erste Asset Management held its Denali Therapeutics (DNLI) position steady in Q2 2026 at 26,900 shares worth $696K. The position accounts for 0.01% of the portfolio, ranked #486.

Erste Asset Management first reported a position in DNLI in Q4 2018 and has held it in 31 quarters since. The position peaked at $5.11M in Q3 2020. 53 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

Erste Asset Management held 26,900 shares of Denali Therapeutics worth $696K as of Q2 2026.
Erste Asset Management left its Denali Therapeutics share count unchanged in Q2 2026.
Denali Therapeutics made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #486 holding.
Erste Asset Management first reported a position in Denali Therapeutics in Q4 2018 and has held it in 31 quarters since.
Erste Asset Management's Denali Therapeutics position peaked at $5.11M in Q3 2020.
53 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.